sales@fnfresearch.comTel: +86 21 80360450 | USA: +1-347-989-3985

Search Market Research Report

Home / Healthcare / Uveitis Treatment

Uveitis Treatment Market By Treatment type (corticosteroids, immunosuppressant, monoclonal antibodies, cycloplegic agents, antibiotics, antivirals, antifungal, and analgesics), Disease type (anterior uveitis, posterior uveitis, intermediate uveitis and panuveitis), Distribution Channel (hospitals, ophthalmology clinics, ambulatory surgical centers, and others) and Regions: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

  • Publish On: Mar-2020
  • Total Pages: 174
  • Report Code: FAF-698
  • Base Year: 2019
  • Format:

Industry Insights

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the uveitis treatment industry. The report analyzes and declares the historical and current trends analysis of the uveitis treatment industry and subsequently recommends the projected trends anticipated to be observed in the uveitis treatment market during the upcoming years.

The uveitis treatment market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire uveitis treatment market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of both volume (Units) and value (USD Million) from FY 2016 – 2026.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the uveitis treatment industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the uveitis treatment industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the uveitis treatment market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders the uveitis treatment involved in the entire value chain of the uveitis treatment industry. The market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the uveitis treatment sector. Key strategic developments in the uveitis treatment market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the uveitis treatment market are appropriately highlighted in the report.

The uveitis treatment market research report delivers an acute valuation and taxonomy of the uveitis treatment industry by practically splitting the market on the basis of different treatment types, disease type, and distribution channels, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the uveitis treatment industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Further, country-wise data for the uveitis treatment industry is provided for the leading economies of the world.

Uveitis disease affects directly the tissues of the eyes and leads to swelling and inflammation. Increasing the prevalence of uveitis globally is a major factor propelling the growth of the target market. Additionally, growth in the number of trials in order to treat eye inflammations conditions worldwide is another factor to boost target market growth in the coming years. However, research and development of such treatments cost a lot which can be the major restraining factor for the growth of the global market over the forecast year.

The global market has been segmented based on treatment type, disease type, and distribution channel. The treatment type segment is classified as monoclonal antibodies, immunosuppressants, corticosteroids, cycloplegic agents, antifungal, analgesics, antibiotics, and antivirals. On the basis of disease type segment, the global market can be bifurcated as posterior uveitis, intermediate uveitis, anterior uveitis, and panuveitis. The distribution channel segment is classified as ambulatory surgical centers, hospitals, others, and ophthalmology clinics. The hospital's segment is expected to account for the largest market share in terms of revenue over the forecast period.

Key players operating in the target market include Allergan, Inc., Novartis AG; Inc., Regeneron Pharmaceuticals, Alimera Sciences, Inc., Bausch & Lomb Incorporated, AbbVie Inc., Santen Pharmaceutical Co., Eyepoint Pharmaceuticals Inc.; Eyegate Pharmaceuticals, and others.

The taxonomy of the uveitis treatment market by its scope and segmentation is as follows:

Global Uveitis Treatment Market: Treatment type Segment Analysis (Customizable)

  • Corticosteroids
  • Immunosuppressant
  • Monoclonal Antibodies
  • Cycloplegic Agents
  • Antibiotics
  • Antivirals
  • Antifungal
  • Analgesics

Global Uveitis Treatment Market: Disease type Segment Analysis (Customizable)

  • Anterior Uveitis
  • Posterior Uveitis
  • Intermediate Uveitis
  • Panuveitis

Global Uveitis Treatment Market: Distribution Channel Segment Analysis (Customizable)

  • Hospitals
  • Ophthalmology Clinics
  • Ambulatory Surgical Centers
  • Others

Global Uveitis Treatment Market: Regional Segmentation Analysis (Customizable)

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

KEY REPORT POINTERS & HIGHLIGHTS:

  • Statistically Validated Analysis of Historical, Current, and Projected Industry Trends with Authenticated Market Sizes Information and Data in terms of Value and Volume, wherever applicable
  • Direct and Indirect Factors that Impacted the Industry as well Projected Rationales expected to affect the industry going forward
  • Micro, Meso, Macro, and In-Depth Analysis of Technically relevant and Commercially viableSegments and Sub-segments of the Market
  • Historical and Projected Company / Vendor / OEM / Supplier Market Shares, Competitive Landscape, and Player Positioning Data
  • Historical and Current Demand (Consumption) and Supply (Production) Scenarios as well as Projected Supply-Demand Scenario Analysis
  • Detailed List of Key Buyers and End-Users (Consumers) analyzed as per Regions and Applications
  • Value Chain and Supply Chain Analysis along with Horizontal and Vertical Integration Scenarios
  • Manufacturing and Production Cost Structure Analysis including Labor Cost, Raw Material Expenses, and Other Manufacturing Expenses, wherever relevant
  • Overview of Key Marketing Strategies and Key Sales Channels Adopted in the Market
  • Market Attractiveness Analysis and Key Investment Opportunity Analysis in the Market going forward
  • Technological Roadmap, Patents Analysis, Potential Substitutes, and Technical Analysis
  • The professionally substantiated market research report study is calculated, constructed, and assembled by implementing a Robust Research Methodology. The Triangular Process comprises abuoyant mix of Exhaustive Primary Research (focused interviews, questionnaires, and ad-hoc surveys) and Extended Secondary Research (paid external databases, proprietary in-house database, and publically-available validated sources), where it is finally triangulated and validated through in-house industry experts, industry leaders, and independent consultants through a tri-level quality check practice.

Table of Content

  1. CHAPTER 1. Executive Summary
  2. CHAPTER 2. Uveitis Treatment market – Treatment type Analysis
    1. 2.1. Global Uveitis Treatment Market – Treatment type Overview
    2. 2.2. Global Uveitis Treatment Market Share, by Treatment type, 2018 & 2025 (USD Million)
    3. 2.3. Corticosteroids
      1. 2.3.1. Global Corticosteroids Uveitis Treatment Market, 2016-2026 (USD Million)
    4. 2.4. Immunosuppressant
      1. 2.4.1. Global Immunosuppressant Uveitis Treatment Market, 2016-2026 (USD Million)
    5. 2.5. Monoclonal Antibodies
      1. 2.5.1. Global Monoclonal Antibodies Uveitis Treatment Market, 2016-2026 (USD Million)
    6. 2.6. Cycloplegic Agents
      1. 2.6.1. Global Cycloplegic Agents Uveitis Treatment Market, 2016-2026 (USD Million)
    7. 2.7. Antibiotics
      1. 2.7.1. Global Antibiotics Uveitis Treatment Market, 2016-2026 (USD Million)
    8. 2.8. Antivirals
      1. 2.8.1. Global Antivirals Uveitis Treatment Market, 2016-2026 (USD Million)
    9. 2.9. Antifungal
      1. 2.9.1. Global Antifungal Uveitis Treatment Market, 2016-2026 (USD Million)
    10. 2.10. Analgesics
      1. 2.10.1. Global Analgesics Uveitis Treatment Market, 2016-2026 (USD Million)
  3. CHAPTER 3. Uveitis Treatment market – Disease type Analysis
    1. 3.1. Global Uveitis Treatment Market – Disease type Overview
    2. 3.2. Global Uveitis Treatment Market Share, by Disease type, 2018 & 2025 (USD Million)
    3. 3.3. Anterior Uveitis
      1. 3.3.1. Global Anterior Uveitis Uveitis Treatment Market, 2016-2026 (USD Million)
    4. 3.4. Posterior Uveitis
      1. 3.4.1. Global Posterior Uveitis Uveitis Treatment Market, 2016-2026 (USD Million)
    5. 3.5. Intermediate Uveitis
      1. 3.5.1. Global Intermediate Uveitis Uveitis Treatment Market, 2016-2026 (USD Million)
    6. 3.6. Panuveitis
      1. 3.6.1. Global Panuveitis Uveitis Treatment Market, 2016-2026 (USD Million)
  4. CHAPTER 4. Uveitis Treatment market – Distribution Channel Analysis
    1. 4.1. Global Uveitis Treatment Market – Distribution Channel Overview
    2. 4.2. Global Uveitis Treatment Market Share, by Distribution Channel, 2018 & 2025 (USD Million)
    3. 4.3. Hospitals
      1. 4.3.1. Global Hospitals Uveitis Treatment Market, 2016-2026 (USD Million)
    4. 4.4. Ophthalmology Clinics
      1. 4.4.1. Global Ophthalmology Clinics Uveitis Treatment Market, 2016-2026 (USD Million)
    5. 4.5. Ambulatory Surgical Centers
      1. 4.5.1. Global Ambulatory Surgical Centers Uveitis Treatment Market, 2016-2026 (USD Million)
    6. 4.6. Others
      1. 4.6.1. Global Others Uveitis Treatment Market, 2016-2026 (USD Million)
  5. CHAPTER 5. Uveitis Treatment market – Regional Analysis
    1. 5.1. Global Uveitis Treatment Market Regional Overview
    2. 5.2. Global Uveitis Treatment Market Share, by Region, 2018 & 2025 (Value)
    3. 5.3. North America
      1. 5.3.1. North America Uveitis Treatment Market size and forecast, 2016-2026
      2. 5.3.2. North America Uveitis Treatment Market, by Country, 2018 & 2025 (USD Million)
      3. 5.3.3. North America Uveitis Treatment Market, by Treatment type, 2016-2026
        1. 5.3.3.1. North America Uveitis Treatment Market, by Treatment type, 2016-2026 (USD Million)
      4. 5.3.4. North America Uveitis Treatment Market, by Disease type, 2016-2026
        1. 5.3.4.1. North America Uveitis Treatment Market, by Disease type, 2016-2026 (USD Million)
      5. 5.3.5. North America Uveitis Treatment Market, by Distribution Channel, 2016-2026
        1. 5.3.5.1. North America Uveitis Treatment Market, by Distribution Channel, 2016-2026 (USD Million)
      6. 5.3.6. U.S.
        1. 5.3.6.1. U.S. Market size and forecast, 2016-2026 (USD Million)
      7. 5.3.7. Canada
        1. 5.3.7.1. Canada Market size and forecast, 2016-2026 (USD Million)
    4. 5.4. Europe
      1. 5.4.1. Europe Uveitis Treatment Market size and forecast, 2016-2026
      2. 5.4.2. Europe Uveitis Treatment Market, by Country, 2018 & 2025 (USD Million)
      3. 5.4.3. Europe Uveitis Treatment Market, by Treatment type, 2016-2026
        1. 5.4.3.1. Europe Uveitis Treatment Market, by Treatment type, 2016-2026 (USD Million)
      4. 5.4.4. Europe Uveitis Treatment Market, by Disease type, 2016-2026
        1. 5.4.4.1. Europe Uveitis Treatment Market, by Disease type, 2016-2026 (USD Million)
      5. 5.4.5. Europe Uveitis Treatment Market, by Distribution Channel, 2016-2026
        1. 5.4.5.1. Europe Uveitis Treatment Market, by Distribution Channel, 2016-2026 (USD Million)
      6. 5.4.6. Germany
        1. 5.4.6.1. Germany Market size and forecast, 2016-2026 (USD Million)
      7. 5.4.7. France
        1. 5.4.7.1. France Market size and forecast, 2016-2026 (USD Million)
      8. 5.4.8. U.K.
        1. 5.4.8.1. U.K. Market size and forecast, 2016-2026 (USD Million)
      9. 5.4.9. Italy
        1. 5.4.9.1. Italy Market size and forecast, 2016-2026 (USD Million)
      10. 5.4.10. Spain
        1. 5.4.10.1. Spain Market size and forecast, 2016-2026 (USD Million)
      11. 5.4.11. Rest of Europe
        1. 5.4.11.1. Rest of Europe Market size and forecast, 2016-2026 (USD Million)
    5. 5.5. Asia Pacific
      1. 5.5.1. Asia Pacific Uveitis Treatment Market size and forecast, 2016-2026
      2. 5.5.2. Asia Pacific Uveitis Treatment Market, by Country, 2018 & 2025 (USD Million)
      3. 5.5.3. Asia Pacific Uveitis Treatment Market, by Treatment type, 2016-2026
        1. 5.5.3.1. Asia Pacific Uveitis Treatment Market, by Treatment type, 2016-2026 (USD Million)
      4. 5.5.4. Asia Pacific Uveitis Treatment Market, by Disease type, 2016-2026
        1. 5.5.4.1. Asia Pacific Uveitis Treatment Market, by Disease type, 2016-2026 (USD Million)
      5. 5.5.5. Asia Pacific Uveitis Treatment Market, by Distribution Channel, 2016-2026
        1. 5.5.5.1. Asia Pacific Uveitis Treatment Market, by Distribution Channel, 2016-2026 (USD Million)
      6. 5.5.6. China
        1. 5.5.6.1. China Market size and forecast, 2016-2026 (USD Million)
      7. 5.5.7. Japan
        1. 5.5.7.1. Japan Market size and forecast, 2016-2026 (USD Million)
      8. 5.5.8. India
        1. 5.5.8.1. India Market size and forecast, 2016-2026 (USD Million)
      9. 5.5.9. South Korea
        1. 5.5.9.1. South Korea Market size and forecast, 2016-2026 (USD Million)
      10. 5.5.10. South-East Asia
        1. 5.5.10.1. South-East Asia Market size and forecast, 2016-2026 (USD Million)
      11. 5.5.11. Rest of Asia Pacific
        1. 5.5.11.1. Rest of Asia Pacific Market size and forecast, 2016-2026 (USD Million)
    6. 5.6. Latin America
      1. 5.6.1. Latin America Uveitis Treatment Market size and forecast, 2016-2026
      2. 5.6.2. Latin America Uveitis Treatment Market, by Country, 2018 & 2025 (USD Million)
      3. 5.6.3. Latin America Uveitis Treatment Market, by Treatment type, 2016-2026
        1. 5.6.3.1. Latin America Uveitis Treatment Market, by Treatment type, 2016-2026 (USD Million)
      4. 5.6.4. Latin America Uveitis Treatment Market, by Disease type, 2016-2026
        1. 5.6.4.1. Latin America Uveitis Treatment Market, by Disease type, 2016-2026 (USD Million)
      5. 5.6.5. Latin America Uveitis Treatment Market, by Distribution Channel, 2016-2026
        1. 5.6.5.1. Latin America Uveitis Treatment Market, by Distribution Channel, 2016-2026 (USD Million)
      6. 5.6.6. Brazil
        1. 5.6.6.1. Brazil Market size and forecast, 2016-2026 (USD Million)
      7. 5.6.7. Mexico
        1. 5.6.7.1. Mexico Market size and forecast, 2016-2026 (USD Million)
      8. 5.6.8. Rest of Latin America
        1. 5.6.8.1. Rest of Latin America Market size and forecast, 2016-2026 (USD Million)
    7. 5.7. The Middle-East and Africa
      1. 5.7.1. The Middle-East and Africa Uveitis Treatment Market size and forecast, 2016-2026
      2. 5.7.2. The Middle-East and Africa Uveitis Treatment Market, by Country, 2018 & 2025 (USD Million)
      3. 5.7.3. The Middle-East and Africa Uveitis Treatment Market, by Treatment type, 2016-2026
        1. 5.7.3.1. The Middle-East and Africa Uveitis Treatment Market, by Treatment type, 2016-2026 (USD Million)
      4. 5.7.4. The Middle-East and Africa Uveitis Treatment Market, by Disease type, 2016-2026
        1. 5.7.4.1. The Middle-East and Africa Uveitis Treatment Market, by Disease type, 2016-2026 (USD Million)
      5. 5.7.5. The Middle-East and Africa Uveitis Treatment Market, by Distribution Channel, 2016-2026
        1. 5.7.5.1. The Middle-East and Africa Uveitis Treatment Market, by Distribution Channel, 2016-2026 (USD Million)
      6. 5.7.6. GCC Countries
        1. 5.7.6.1. GCC Countries Market size and forecast, 2016-2026 (USD Million)
      7. 5.7.7. South Africa
        1. 5.7.7.1. South Africa Market size and forecast, 2016-2026 (USD Million)
      8. 5.7.8. Rest of Middle-East Africa
        1. 5.7.8.1. Rest of Middle-East Africa Market size and forecast, 2016-2026 (USD Million)
  6. CHAPTER 6. Uveitis Treatment market – Competitive Landscape
    1. 6.1. Competitor Market Share – Revenue
    2. 6.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 6.3. Strategic Development
      1. 6.3.1. Acquisitions and Mergers
      2. 6.3.2. New Products
      3. 6.3.3. Research & Development Activities
  7. CHAPTER 7. Company Profiles
    1. 7.1. Allergan, Inc.
      1. 7.1.1. Company Overview
      2. 7.1.2. Allergan, Inc. Revenue and Gross Margin
      3. 7.1.3. Product portfolio
      4. 7.1.4. Recent initiatives
    2. 7.2. Bausch & Lomb Incorporated
      1. 7.2.1. Company Overview
      2. 7.2.2. Bausch & Lomb Incorporated Revenue and Gross Margin
      3. 7.2.3. Product portfolio
      4. 7.2.4. Recent initiatives
    3. 7.3. Santen Pharmaceutical Co., Ltd
      1. 7.3.1. Company Overview
      2. 7.3.2. Santen Pharmaceutical Co., Ltd Revenue and Gross Margin
      3. 7.3.3. Product portfolio
      4. 7.3.4. Recent initiatives
    4. 7.4. AbbVie Inc.
      1. 7.4.1. Company Overview
      2. 7.4.2. AbbVie Inc. Revenue and Gross Margin
      3. 7.4.3. Product portfolio
      4. 7.4.4. Recent initiatives
    5. 7.5. Novartis AG
      1. 7.5.1. Company Overview
      2. 7.5.2. Novartis AG Revenue and Gross Margin
      3. 7.5.3. Product portfolio
      4. 7.5.4. Recent initiatives
    6. 7.6. Eyegate Pharmaceuticals, Inc.
      1. 7.6.1. Company Overview
      2. 7.6.2. Eyegate Pharmaceuticals, Inc. Revenue and Gross Margin
      3. 7.6.3. Product portfolio
      4. 7.6.4. Recent initiatives
    7. 7.7. Regeneron Pharmaceuticals
      1. 7.7.1. Company Overview
      2. 7.7.2. Regeneron Pharmaceuticals Revenue and Gross Margin
      3. 7.7.3. Product portfolio
      4. 7.7.4. Recent initiatives
    8. 7.8. Eyepoint pharmaceuticals Inc.
      1. 7.8.1. Company Overview
      2. 7.8.2. Eyepoint pharmaceuticals Inc. Revenue and Gross Margin
      3. 7.8.3. Product portfolio
      4. 7.8.4. Recent initiatives
    9. 7.9. Alimera Sciences, Inc.
      1. 7.9.1. Company Overview
      2. 7.9.2. Alimera Sciences, Inc. Revenue and Gross Margin
      3. 7.9.3. Product portfolio
      4. 7.9.4. Recent initiatives
  8. CHAPTER 8. Uveitis Treatment — Industry Analysis
    1. 8.1. Uveitis Treatment Market – Key Trends
      1. 8.1.1. Market Drivers
      2. 8.1.2. Market Restraints
      3. 8.1.3. Market Opportunities
    2. 8.2. Value Chain Analysis
    3. 8.3. Technology Roadmap and Timeline
    4. 8.4. Uveitis Treatment Market – Attractiveness Analysis
      1. 8.4.1. By Treatment type
      2. 8.4.2. By Disease type
      3. 8.4.3. By Distribution Channel
      4. 8.4.4. By Region
  9. CHAPTER 9. Marketing Strategy Analysis, Distributors
    1. 9.1. Marketing Channel
    2. 9.2. Direct Marketing
    3. 9.3. Indirect Marketing
    4. 9.4. Marketing Channel Development Trend
    5. 9.5. Economic/Political Environmental Change
  10. CHAPTER 10. Report Conclusion
  11. CHAPTER 11. Research Approach & Methodology
    1. 11.1. Report Description
    2. 11.2. Research Scope
    3. 11.3. Research Methodology
      1. 11.3.1. Secondary Research
      2. 11.3.2. Primary Research
      3. 11.3.3. Models
        1. 11.3.3.1. Company Share Analysis Model
        2. 11.3.3.2. Revenue Based Modeling
        3. 11.3.3.3. Research Limitations

        List of Figures

        FIG. 1 Global Uveitis Treatment Market, 2016-2026 (USD Million)
        FIG. 2 Global Uveitis Treatment Market Share, by Treatment type, 2018 & 2025 (USD Million)
        FIG. 3 Global Corticosteroids Uveitis Treatment Market, 2016-2026 (USD Million)
        FIG. 4 Global Immunosuppressant Uveitis Treatment Market, 2016-2026 (USD Million)
        FIG. 5 Global Monoclonal Antibodies Uveitis Treatment Market, 2016-2026 (USD Million)
        FIG. 6 Global Cycloplegic Agents Uveitis Treatment Market, 2016-2026 (USD Million)
        FIG. 7 Global Antibiotics Uveitis Treatment Market, 2016-2026 (USD Million)
        FIG. 8 Global Antivirals Uveitis Treatment Market, 2016-2026 (USD Million)
        FIG. 9 Global Antifungal Uveitis Treatment Market, 2016-2026 (USD Million)
        FIG. 10 Global Analgesics Uveitis Treatment Market, 2016-2026 (USD Million)
        FIG. 11 Global Uveitis Treatment Market Share, by Disease type, 2018 & 2025 (USD Million)
        FIG. 12 Global Anterior Uveitis Uveitis Treatment Market, 2016-2026 (USD Million)
        FIG. 13 Global Posterior Uveitis Uveitis Treatment Market, 2016-2026 (USD Million)
        FIG. 14 Global Intermediate Uveitis Uveitis Treatment Market, 2016-2026 (USD Million)
        FIG. 15 Global Panuveitis Uveitis Treatment Market, 2016-2026 (USD Million)
        FIG. 16 Global Uveitis Treatment Market Share, by Distribution Channel, 2018 & 2025 (USD Million)
        FIG. 17 Global Hospitals Uveitis Treatment Market, 2016-2026 (USD Million)
        FIG. 18 Global Ophthalmology Clinics Uveitis Treatment Market, 2016-2026 (USD Million)
        FIG. 19 Global Ambulatory Surgical Centers Uveitis Treatment Market, 2016-2026 (USD Million)
        FIG. 20 Global Others Uveitis Treatment Market, 2016-2026 (USD Million)
        FIG. 21 Global Uveitis Treatment Market Share, by Region, 2018 & 2025
        FIG. 22 North America Uveitis Treatment Market, 2016-2026
        FIG. 23 U.S. Uveitis Treatment Market, 2016-2026
        FIG. 24 Canada Uveitis Treatment Market, 2016-2026
        FIG. 25 Europe Uveitis Treatment Market, 2016-2026
        FIG. 26 Germany Uveitis Treatment Market, 2016-2026
        FIG. 27 France Uveitis Treatment Market, 2016-2026
        FIG. 28 U.K. Uveitis Treatment Market, 2016-2026
        FIG. 29 Italy Uveitis Treatment Market, 2016-2026
        FIG. 30 Spain Uveitis Treatment Market, 2016-2026
        FIG. 31 Rest of Europe Uveitis Treatment Market, 2016-2026
        FIG. 32 Asia Pacific Uveitis Treatment Market, 2016-2026
        FIG. 33 China Uveitis Treatment Market, 2016-2026
        FIG. 34 Japan Uveitis Treatment Market, 2016-2026
        FIG. 35 India Uveitis Treatment Market, 2016-2026
        FIG. 36 South  Korea Uveitis Treatment Market, 2016-2026
        FIG. 37 South-East Asia Uveitis Treatment Market, 2016-2026
        FIG. 38 Rest of Asia Pacific Uveitis Treatment Market, 2016-2026
        FIG. 39 Latin America Uveitis Treatment Market, 2016-2026
        FIG. 40 Brazil Uveitis Treatment Market, 2016-2026
        FIG. 41 Mexico Uveitis Treatment Market, 2016-2026
        FIG. 42 Rest of Latin America Uveitis Treatment Market, 2016-2026
        FIG. 43 The Middle-East and Africa Uveitis Treatment Market, 2016-2026
        FIG. 44 GCC Countries Uveitis Treatment Market, 2016-2026
        FIG. 45 South Africa Uveitis Treatment Market, 2016-2026
        FIG. 46 Rest of Middle-East Africa Uveitis Treatment Market, 2016-2026
        FIG. 47 Competitor Market Share – Revenue
        FIG. 48 Allergan, Inc. Revenue and Growth Rate
        FIG. 49 Allergan, Inc. Market Share
        FIG. 50 Bausch & Lomb Incorporated Revenue and Growth Rate
        FIG. 51 Bausch & Lomb Incorporated Market Share
        FIG. 52 Santen Pharmaceutical Co., Ltd Revenue and Growth Rate
        FIG. 53 Santen Pharmaceutical Co., Ltd Market Share
        FIG. 54 AbbVie Inc. Revenue and Growth Rate
        FIG. 55 AbbVie Inc. Market Share
        FIG. 56 Novartis AG Revenue and Growth Rate
        FIG. 57 Novartis AG Market Share
        FIG. 58 Eyegate Pharmaceuticals, Inc. Revenue and Growth Rate
        FIG. 59 Eyegate Pharmaceuticals, Inc. Market Share
        FIG. 60 Regeneron Pharmaceuticals Revenue and Growth Rate
        FIG. 61 Regeneron Pharmaceuticals Market Share
        FIG. 62 Eyepoint pharmaceuticals Inc. Revenue and Growth Rate
        FIG. 63 Eyepoint pharmaceuticals Inc. Market Share
        FIG. 64 Alimera Sciences, Inc. Revenue and Growth Rate
        FIG. 65 Alimera Sciences, Inc. Market Share
        FIG. 66 Market Dynamics
        FIG. 67 Global Uveitis Treatment – Value Chain Analysis
        FIG. 68 Technology Roadmap and Timeline
        FIG. 69 Market Attractiveness Analysis – By Treatment type
        FIG. 70 Market Attractiveness Analysis – By Disease type
        FIG. 71 Market Attractiveness Analysis – By Distribution Channel
        FIG. 72 Market Attractiveness Analysis – By Region
        FIG. 73 Market Channel
        FIG. 74 Marketing Channel Development Trend
        FIG. 75 Growth in World Gross Product, 2008-2018

        List of Tables

        TABLE 1 Global Uveitis Treatment Market, 2018 & 2025 (USD Million)
        TABLE 2 Global Uveitis Treatment market, by Treatment type, 2016-2026 (USD Million)
        TABLE 3 Global Uveitis Treatment market, by Disease type, 2016-2026 (USD Million)
        TABLE 4 Global Uveitis Treatment market, by Distribution Channel, 2016-2026 (USD Million)
        TABLE 5 Global Uveitis Treatment market, by Region, 2016-2026 (USD Million)
        TABLE 6 North America Uveitis Treatment Market, by Treatment type, 2016-2026 (USD Million)
        TABLE 7 North America Uveitis Treatment Market, by Disease type, 2016-2026 (USD Million)
        TABLE 8 North America Uveitis Treatment Market, by Distribution Channel, 2016-2026 (USD Million)
        TABLE 9 Europe Uveitis Treatment Market, by Treatment type, 2016-2026 (USD Million)
        TABLE 10 Europe Uveitis Treatment Market, by Disease type, 2016-2026 (USD Million)
        TABLE 11 Europe Uveitis Treatment Market, by Distribution Channel, 2016-2026 (USD Million)
        TABLE 12 Asia Pacific Uveitis Treatment Market, by Treatment type, 2016-2026 (USD Million)
        TABLE 13 Asia Pacific Uveitis Treatment Market, by Disease type, 2016-2026 (USD Million)
        TABLE 14 Asia Pacific Uveitis Treatment Market, by Distribution Channel, 2016-2026 (USD Million)
        TABLE 15 Latin America Uveitis Treatment Market, by Treatment type, 2016-2026 (USD Million)
        TABLE 16 Latin America Uveitis Treatment Market, by Disease type, 2016-2026 (USD Million)
        TABLE 17 Latin America Uveitis Treatment Market, by Distribution Channel, 2016-2026 (USD Million)
        TABLE 18 The Middle-East and Africa Uveitis Treatment Market, by Treatment type, 2016-2026 (USD Million)
        TABLE 19 The Middle-East and Africa Uveitis Treatment Market, by Disease type, 2016-2026 (USD Million)
        TABLE 20 The Middle-East and Africa Uveitis Treatment Market, by Distribution Channel, 2016-2026 (USD Million)
        TABLE 21 Global Uveitis Treatment Market - Company Revenue Analysis 2016-2019 (USD Million)
        TABLE 22 Global Uveitis Treatment Market - Company Revenue Share Analysis 2016-2019(%)
        TABLE 23 Acquisitions and Mergers
        TABLE 24 New Product/Service Launch
        TABLE 25 Research & Development Activities
        TABLE 26 Market Drivers
        TABLE 27 Market Restraints
        TABLE 28 Market Opportunities

Key Insights from Primary Research

  • As per our primary respondents, the global uveitis treatment market is set to grow annually at a rate of around 6%
  • It was established through primary research that the global uveitis treatment market was valued at around 450USD billion in 2019
  • The “Hospital” category, on the basis of distribution channel segmentation, is expected to dominate in terms of revenue, over the forecast period
  • Based on the region, North America is expected to account for the revenue share in 2019 in the target market

Key Recommendations from Analysts

  • As per our analysts, global uveitis treatment is growing at high CAGR and various end-use industries are aware of this potential market and applications of uveitis treatment
  • Growing at a CAGR around 6.1%, global uveitis treatment market provides numerous opportunities for all of the involved stakeholders across the entire value chain
  • Our analysts have identified hospital are dominating segment for global uveitis treatment market in terms of distribution channel segmentation

Market Share – By Distribution Channel

Uveitis Treatment Market

Industry Major Market Players

  •  Allergan Inc.
  •  Novartis AG Inc
  •  Regeneron Pharmaceuticals
  •  Alimera Sciences  Inc.
  •  Bausch & Lomb Incorporated
  •  AbbVie Inc.
  •  Santen Pharmaceutical Co.
  •  Eyepoint pharmaceuticals Inc.
  •  Eyegate Pharmaceuticals

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2020 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions